Expert Pitch

Business experts are available to comment on the challenges of COVID-19 vaccine shortages, distribution, and demand.

Indiana University
29-Jan-2021 4:15 PM EST, by Indiana University

INDIANAPOLIS and BLOOMINGTON, Ind. -- Alleviating the coronavirus pandemic rests on worldwide vaccination efforts, but many countries are reporting dwindling supplies of the COVID-19 vaccine. At the same time, the Biden administration aims to buy 200 million more doses, to provide enough vaccine for the entire adult U.S. population by the end of the summer. How will drugmakers like Moderna and Pfizer be able to meet the demand and handle the enormous logistical challenges of distributing doses? Experts from Indiana University Bloomington and IUPUI are available to discuss these topics.

Amrou Awaysheh

Expertise: Corporate social responsibility, operations management, supply chain management, data science and analytics, business innovation, disruptive technology.

Amrou Awaysheh is an assistant professor of operations management at the Kelley School of Business. He is also the director of the Global Supply Chain Enterprise. His research focuses on how firms manage socially responsible practices in their operations and supply chains and the impact that has on firm performance.

Kyle Cattani

Expertise: Operations management, supply chain management, managing operations in the presence of uncertainty, managing product end-of-life, mass customization.

A member of the IU Kelley School of Business faculty since 2005, Kyle Cattani is professor of operations management, chair of the Full-Time MBA Program and the SungKyunKwan Professor. Since 2017, he has served as associate editor of the Journal of Operations Management, and he also is senior editor at Production and Operations Management Society.

Maryam Khatami

Expertise: Stochastic programming, healthcare systems engineering, supply chain management, energy

Maryam Khatami is an expert on stochastic programming applied to healthcare systems engineering, supply chain management, and energy. She has the experience of collaborating with several hospitals to improve patient flow and reduce congestion in hospitals, more specifically in the emergency department. She has also conducted research on supply chain network design and location-routing problems. She develops rigorous mathematical models to formulate and solve these problems using real data​. She received her Ph.D. in Industrial and Systems Engineering from Texas A&M University and B.S. and M.S. degrees in industrial engineering from Amirkabir University of Technology, Iran.

Mohan Tatikonda

Expertise: International trade, Lean Six Sigma, complex new product and service development, startup firms, supply chain management, global competition, corporate strategy, international manufacturing competitiveness, entrepreneurship, incubators, health care delivery, life sciences.

Mohan Tatikonda is a professor of operations management at the Indiana University Kelley School of Business whose research focuses on how firms can most effectively design, develop, introduce and improve products, services and organizational processes. His research addresses managing development projects in global environments, fostering technology transfer in the supply chain, behavioral decision-making by supply chain managers, six-sigma program and project effectiveness, and the consumer privacy implications of RFID technology and other advanced technologies.



Filters close

Showing results

110 of 5863
Released: 24-Jun-2021 6:05 AM EDT
Longest known SARS-CoV-2 infection of nearly 300 days successfully treated with new therapy
University of Bristol

An immunocompromised individual with the longest known PCR confirmed case of SARS-CoV-2 infection, lasting more than 290 days, has been successfully treated with two investigational monoclonal antibodies (laboratory engineered antibodies). Clinicians and researchers from the University of Bristol and North Bristol NHS Trust (NBT) worked closely to assess and treat the infection and want to highlight the urgent need for improved access to treatments for such people with persistent SARS-CoV-2 infection.

Released: 23-Jun-2021 3:55 PM EDT
Cooperative Extension grant aims to vaccinate NYS’ vulnerable
Cornell University

A two-year, $200,000 grant from the USDA and the Extension Foundation to Cornell University researchers aims to help promote vaccine confidence and uptake in vulnerable communities in eight New York counties, both upstate and downstate.

Released: 23-Jun-2021 12:10 PM EDT
Phone swabs can accurately detect COVID-19
University College London

An accurate, non-invasive, and low-cost method of testing for COVID-19 using samples taken from the screens of mobile phones has been developed by a team led by UCL researchers at Diagnosis Biotech.

Newswise: NIH study suggests COVID-19 prevalence far exceeded early pandemic cases
Released: 23-Jun-2021 11:35 AM EDT
NIH study suggests COVID-19 prevalence far exceeded early pandemic cases
National Institute of Biomedical Imaging and Bioengineering

In a new study, NIH researchers report that the prevalence of COVID-19 in the United States during spring and summer of 2020 far exceeded the known number of cases and that infection affected the country unevenly.

Released: 23-Jun-2021 11:25 AM EDT
Half of young adults with covid-19 have persistent symptoms 6 months after
University of Bergen

A paper published in the prestigious journal Nature Medicine on long-COVID, describes persistent symptoms six months after acute COVID-19, even in young home isolated people.

Newswise:Video Embedded covid-19-vaccine-hesitancy-dr-vin-gupta-narrates-new-american-thoracic-society-video
VIDEO
Released: 23-Jun-2021 9:40 AM EDT
COVID-19 Vaccine Hesitancy: Dr. Vin Gupta Narrates New American Thoracic Society Video
American Thoracic Society (ATS)

The American Thoracic Society rolls out a new video to address vaccine hesitancy and answer common questions amid the COVID-19 pandemic.

18-Jun-2021 11:00 AM EDT
Had COVID-19? One Vaccine Dose Enough; Boosters For All, Study Says
American Chemical Society (ACS)

A new study in ACS Nano supports increasing evidence that people who had COVID-19 need only one vaccine dose, and that boosters could be necessary for everyone in the future.

Released: 22-Jun-2021 5:10 PM EDT
Tecnología de inteligencia artificial y ECG puede rápidamente descartar infección por COVID-19
Mayo Clinic

La inteligencia artificial puede ofrecer un manera de determinar con exactitud que una persona no está infectada con la COVID-19. Un estudio internacional y retrospectivo descubrió que la infección por SARS-CoV-2, el virus que causa la COVID-19, provoca sutiles cambios eléctricos en el corazón. Un electrocardiograma (ECG) mediado por inteligencia artificial detecta estos cambios y puede servir como una prueba rápida y confiable para descartar la infección por COVID-19.

Released: 22-Jun-2021 4:45 PM EDT
Penn Medicine to Use $1M from City of Philadelphia for Additional Community Vaccination Clinics
Perelman School of Medicine at the University of Pennsylvania

Penn Medicine will continue its collaboration with the West and Southwest Philadelphia communities to operate a series of COVID-19 vaccine clinics in partnership with community organizations, faith-based institutions, restaurants, barbershops, and even professional sports teams thanks to $1 million in funding from the City of Philadelphia, in partnership with PMHCC.

Released: 22-Jun-2021 12:30 PM EDT
Political Variables Carried More Weight Than Healthcare in Government Response to COVID-19
Binghamton University, State University of New York

Political institutions such as the timing of elections and presidentialism had a larger influence on COVID-19 strategies than the institutions organizing national healthcare, according to a research team led by a professor at Binghamton University, State University of New York.


Showing results

110 of 5863

close
1.48751